UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

The results of ongoing research by Amprologix, a spinout company at the University of Plymouth, will be presented to leading ...

Antibiotic resistance is a global health challenge that could overtake cancer mortality within a few decades. In a new study, researchers at Umeå University, Sweden, show that the emergence of ...

Researchers at Penn recently discovered antibiotics derived from the secretions of frogs that can effectively kill bacteria ...

The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

This Research Topic highlights the alarming potential impact of antimicrobial resistance, which is projected to cause 10 million deaths annually by 2050.

IRBM is a contract research organization (CRO) focused on early-stage drug discovery. With a track record of delivering ...

New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...